Translocation 21;22 may be involved in control of differentiation in erythroleukemia.
Fujisawa
S
S
Motomura
S
S
Fujimaki
K
K
Okubo
T
T
D002454:Cell Differentiation / Q000187:drug effects; D002891:Chromosomes, Human, Pair 21 / Q000648:ultrastructure*; D002892:Chromosomes, Human, Pair 22 / Q000648:ultrastructure*; D050676:Core Binding Factor Alpha 2 Subunit; D004268:DNA-Binding Proteins; D015672:Erythroid Precursor Cells / Q000473:pathology; D004920:Erythropoiesis / Q000235:genetics*; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000235:genetics / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics / Q000502:physiology; D011518:Proto-Oncogene Proteins; D014157:Transcription Factors / Q000235:genetics / Q000502:physiology; D014178:Translocation, Genetic
D050676:Core Binding Factor Alpha 2 Subunit; D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; C493728:RUNX1 protein, human; D014157:Transcription Factors